CASP3 and hyperhomocysteinemia: In studies related to cardiomyopathy, metformin inhibits apoptosis by reducing the expression of Cleaved-caspase-3, thereby attenuating hyperhomocysteinemia-induced cardiac hypertrophy and cardiac fibrosis (Zhao et al., 2021).